logo
Share SHARE
FONT-SIZE Plus   Neg

ARRIS Group Q1 Profit Down - Quick Facts

ARRIS Group Inc. (ARRS) announced preliminary and unaudited financial results for the first quarter 2012. GAAP net income in the first quarter 2012 was $5.80 million or $0.05 per share, compared to $11.56 million or $0.09 per share in the year ago quarter.

Adjusted net income in the first quarter 2012 was $0.19 per share, compared to $0.16 per diluted share for the first quarter 2011.

Revenues in the first quarter 2012 were $302.9 million as compared to first quarter 2011 revenues of $267.4 million.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.15 per share on revenues of $296.35 million for the quarter. Analysts' estimates typically exclude special items.

For the second quarter 2012, the company now project that revenues will be in the range of $330 to $350 million, with adjusted net income per share in the range of $0.20 to $0.24 and GAAP net income per share in the range of $0.10 to $0.14.

Analysts expect the company to report earnings of $0.20 per share on revenues of $312.32 million for the second-quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amazon.com Inc. is working on developing a pair of smart glasses that would allow to summon and interact with virtual assistant Alexa while wearing the device, the Financial Times reported, citing people familiar with the plans. The glasses, which would be required to be connected wirelessly to a smartphone to work, is reportedly designed to look like a regular pair of spectacles. Employees at Bombardier Inc.'s aerospace plant in Toronto plan to walk out of the facility on Wednesday morning. The move is an attempt to put pressure on Boeing Co. to drop a trade complaint against the Canadian plane and train maker. The Baltimore Ravens, a professional American football team, postponed its "DNA Day" event just hours before this season's home opener last Sunday. Orig3n Inc., a Boston-based biotech company sponsoring the event, said in a statement that it is "working to address questions from officials from the state of Maryland."
comments powered by Disqus
Follow RTT